Public Health England have published new data from the ongoing Unlinked Anonymous Monitoring Survey of HIV and Viral Hepatitis among People Who Inject Drugs.
В отчете также отражены основные механизмы, используемые представителями гражданского сообщества (неправительственных организаций (НПО)), занимающихся проблемами доступа к лечению вирусных гепатитов в регионе для улучшения доступа к лечению.
A review of the current epidemiological situation viral hepatitis B and C in Eastern Europe and Central Asia (EECA) and responses from government and civil society representatives.
Under the iron law of Prohibition, efforts to interrupt and suppress the illicit drug supply produce economic and logistical pressures favouring evermore compact substitutes.
Human Rights Watch analysis has found that Guatemala’s lack of effort to ensure access to palliative care condemns many patients with pain to needless suffering, with devastating consequences for them and their families.
Winstock, Eastwood and Stevens detail how the new UK drug strategy, almost devoid of harm reduction initiatives, will fail to reduce rapidly increasing numbers of drug-related deaths.
The EMCDDA offers an overview on naloxone access in the European Union and summarises the effectiveness of hand-out naloxone programmes to save the lives of people at risk of overdosing as well as giving recommendations for the future.
